FDA Investigator LT Richard A Lyght

LT Richard A Lyght has inspections in 9 countries as of 10 Jan 2024. LT Richard A Lyght has collaborated with a combinined 3587 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
127
Last Inspection Date:
10 Jan 2024
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Germany, China, India, Poland, Brazil, Mexico, Czechia, Greece
Co-Investigator(s):
Adam R Cooke, Alice S Tsao, Amanda L Fyles, Amir Alavi, Amy Devlin, PhD, Anabel Veiga, Anastasia G Lolas, Andrea Siegel, PhD, Anjali Shukla, PhD, Arie C Menachem, Ariel Cruz Figueroa, Arsen Karapetyan, Azza Talaat, Benita C Okeke, Benton M Ketron, Bill Tacket, Jr, Binh T Nguyen, Bo Chi, PhD, Bonita S Chester, Brien C Fox, Brittani N Franklin, Brooke K Higgins, Brunilda Torres, Bryan A Galvez, Carla J Lundi, Carolina D Vasquez, Caroline Strasinger, Carr Sharpe, Carrie A Hughes, Caryn M Mcnab, CDR Ileana Barreto Pettit, CDR Sean T Creighton, Chaltu N Wakijra, Chantae D Mitchell, Chelsea N Sealey, Cheryl A Clausen, Cheryl A Grandinetti, Chinyere A Asanya, Christopher T Smith, Christos G Tsingelis, Clara E Santiago, Colleen M Aspinwall, Craig A Garmendia, Craig T Rybus, Daryl A Dewoskin, David P King, Dawn M Mccabe, Deborah A Greco, Delkis J Caycedo, Dell S Moller, Dennis Cantellops Paite, Dianiris C Ayala, Dipti Kalra, Donald C Obenhuber, PhD, Donna Mwilliams Hill, Douglas Florentino, Dusty F Snoeberg, Eduardo Carbonell, Edwin J Gorney, Elizabeth D Connell, Emily A Baldwin, Emily A Green, Eric R Holm, Esther B Gamallo Herrera, Frances Namuswe, PhD, Gabriel E Muniz, Gale E Ryan, Gayle S Lawson, Gene D Arcy, Gene R Gunn, Gerardo Z Vazquez, German Rivera, Glenn S Quintanilla, Haley H Seymour, Heather M Bullock, Hecter Jcolon Torres, Hector J Colon Torres, Heidy C Perales, Hugh M Mcclure, II, Iram R Hassan, PhD, James M Timper Jr, James To Neal, Jared P Stevens, Jee Chung, PhD, Jeffrey P Raimondi, Jennifer L Huntington, Jennifer Lalama, Jennifer M Menendez, Jennifer Swisher, PhD, Jessica L Pressley, Joanne E King, John B Crowe, John J Bernal, Jonathan D Green, Jonathan R Campos, Jonathan W Chapman, Jorge L Lajara, Ka L Wong, Kalavati Suvarna, PhD, Karen M Cooper, Katherine E Jacobitz, Kathy Chiu, Kathy Kuo, Kathy Lee, Kayla V Sprague, Kelley, Kelly M Byers, Kenneth H Williams, Kevin Lee, Kevin T Nguyen, Kham Phommachanh, Kim Lthomas Cruse, Kim Thomas Chase, Kimberly A Dutzek, Lacey J Chessor, Ladislav Kermet, Lareese K Thomas, Laurimer Kuilan Torres, LCDR Angelica M Chica, Leon L Crawley, Lillian Mcolon Mcknight, Linda Thai, Lucas B Leake, Luz I Collado, Madushini Dharmasena, PhD, Marc Balzarini, Maria Gutierrez Lugo, PhD, Marie F Morin, Marinee Flores Marrero, Mary E Farbman, PhD, Matthew F Duff, Megan K Otero, Michael C Lombardi, Michael D Garcia, Michael D Kawalek, Michael S Call, Michael Shanks, MS, Michelle S Dunaway, Muralidhara B Gavini, PhD, Neal L Adams, Nebil A Oumer, Nicholas L Hunt, Nicole E Knowlton, Noreen Muniz, Ormond, Paul L Figarole, Jr, Rachel A Gomez, Rachel A Peters, Rachel C Harrington, Raymond A Lyn, Jr, Rebecca Rodriguez, Regina T Brown, Reynolds, Richard Ledwidge (nmi), PhD, Richard Lyght, Robert C Coleman, Rocio Guzman Velazquez, Ronald Ifraimov, Roy R Rinc, Rozelle G Smith, Ruth A Williams, Salvatore N Randazzo, Santiago Gallardo Johnson, Sarah E Mcmullen, Sarah Ibrahim, Saundrea A Munroe, Scott R Nichols, PhD, Sean P Desbrow, Shadia Zaman, PhD, Sheila P Barthelemy, Sheri L Stephenson, Sonia M Monges, Stacey F Allard, Stacey F Rivette, State Agency, Steven A Brettler, Steven E Bowen, PhD, Suzanne N Vallez, Tamala P Bogan, Tamala P Magee, Tania Molina, Teresa I Navas, Terri L Dodds, Thuy T Nguyen, LCDR, Thuy Y Nguyen, Tiara M Brown, Tiara Nbrown Crosen, Traci M Armand, Uttaniti Limchumroon (Tom), Vanessa E Coulter, Victor Spanioli, Virgilio F Pacio, CSO, Viviana Matta, Walden H Lee, Xiaoshi Wang, Youmin Wang, Yumi J Hiramine, Yvins Dezan, Zachary L Miller, Zachary P Wachlarowicz, Zhihao Qiu (Peter), PhD

LT Richard A Lyght's Documents

Publish Date Document Type Title
December, 2016 FDA 483 Vladimir Santos, MD - Form 483, 2016-12-14
July, 2019 FDA 483 Aveva Drug Delivery Systems Inc. - Form 483, 2019-07-26
May, 2019 FDA 483 Juan Fernandez, M.D. - Form 483, 2019-05-21
April, 2017 FDA 483 Yvelice Villaman-Bencosme - Form 483, 2017-05-02
May, 2017 FDA 483 Armas Eddie, MD - Form 483, 2017-05-02
July, 2017 FDA 483 Daniel F. Mandri, M.D. - Form 483, 2017-07-18
January, 2021 FDA 483 David J. De La Zerda, MD - Form 483, 2021-01-13
June, 2023 FDA 483 Maria I. Bermudez, M.D. - Form 483, 2023-06-28
June, 2022 FDA 483 Ophtec USA, Inc. - Form 483, 2022-06-24
June, 2022 FDA 483 U.S. Investigational Review Board Inc. - Form 483, 2022-06-06
January, 2016 FDA 483 Lex Inc - Form 483, 2016-01-20
July, 2022 FDA 483 Maria A. Rodil, M.D. - Form 483, 2022-07-14
April, 2022 FDA 483 Natalia S. Hegedosh, M.D. - Form 483, 2022-04-21
January, 2020 EIR Matthew Teltser MD - EIR, 2020-01-31
March, 2016 EIR Pharmatech LLC - EIR, 2016-03-02
October, 2016 FDA 483 Hadi Yaziji, MD - Form 483, 2016-10-17
February, 2018 FDA 483 Tomas Wharton, MD - Form 483, 2018-02-01
November, 2016 FDA 483 Phase One Solutions, Inc. - Form 483, 2016-11-25
July, 2015 FDA 483 Noven Pharmaceuticals, Inc. - Form 483, 2015-07-10
April, 2017 FDA 483 Fernandez-Miro Humberto, MD - Form 483, 2017-04-13
December, 2021 FDA 483 William E. Sanchez, M.D. - Form 483, 2021-12-22
March, 2016 FDA 483 Piramal Enterprises Limited - Form 483, 2016-03-08
July, 2019 FDA 483 Josefina Tur, MD - Form 483, 2019-07-29
January, 2021 FDA 483 Micron Medical Corporation - Form 483, 2021-01-26
October, 2018 FDA 483 Ramon Garcia-Septien, M.D. - Form 483, 2018-10-10
May, 2022 FDA 483 Hugo Llanes JR, M.D. - Form 483, 2022-05-19
December, 2014 EIR Stratus Pharmaceuticals Inc - EIR, 2014-12-08
June, 2023 FDA 483 Beth E. Safirstein, M.D. - Form 483, 2023-06-05
December, 2014 FDA 483 Stratus Pharmaceuticals Inc - Form 483, 2014-12-08
September, 2018 FDA 483 Martin Valdes, M.D. - Form 483, 2018-09-19
February, 2018 FDA 483 Sandor A. Romero, MD - Form 483, 2018-02-13
July, 2018 FDA 483 Catalyst Pharmaceuticals, Inc. - Form 483, 2018-07-27
March, 2023 FDA 483 Rosa M. Suarez, M.D. - Form 483, 2023-03-10
October, 2015 FDA 483 Proficient Rx LP - Form 483, 2015-10-22
August, 2022 FDA 483 Oscar G. Galvez, M.D. - Form 483, 2022-08-03
October, 2015 EIR Proficient Rx LP - EIR, 2015-10-22
November, 2022 FDA 483 Carlos M. Martinez, M.D. - Form 483, 2022-11-01
July, 2015 FDA 483 Human Genome Sciences, Inc. - Form 483, 2015-07-24
November, 2016 FDA 483 Kenia Castro, M.D. - Form 483, 2016-11-03
December, 2014 FDA 483 Response Stratus Pharmaceuticals Inc - Form 483R, 2014-12-30
July, 2021 FDA 483 Nayvis Iglesias, MD - Form 483, 2021-07-29
October, 2015 FDA 483 Response Proficient Rx LP - Form 483R, 2015-11-12
June, 2017 FDA 483 Department of Veterans Affairs Medical Center - Form 483, 2017-06-16
December, 2022 FDA 483 Caitlin C. Meyer, M.D. - Form 483, 2022-12-21
November, 2018 FDA 483 Jorge Acosta MD - Form 483, 2018-11-28
February, 2023 FDA 483 Manuel F. Fernandez, M.D. - Form 483, 2023-02-17
June, 2021 FDA 483 Enrique S. Hanabergh, MD - Form 483, 2021-06-23
March, 2016 FDA 483 EMCURE PHARMACEUTICALS LIMITED - Form 483, 2016-03-04
September, 2014 FDA 483 Medi-Fare Drug - Form 483, 2014-09-12
May, 2018 FDA 483 Prof. Dr. Jiri Litzman - Form 483, 2018-05-17
January, 2023 FDA 483 Antonio E. Blanco, M.D. - Form 483, 2023-01-30

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more